Correlation Between Bausch Health and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Bausch Health and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bausch Health Companies and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Bausch Health and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Biomarin Pharmaceutical.
Diversification Opportunities for Bausch Health and Biomarin Pharmaceutical
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bausch and Biomarin is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Bausch Health i.e., Bausch Health and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Bausch Health and Biomarin Pharmaceutical
Considering the 90-day investment horizon Bausch Health Companies is expected to under-perform the Biomarin Pharmaceutical. In addition to that, Bausch Health is 1.85 times more volatile than Biomarin Pharmaceutical. It trades about -0.31 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.03 per unit of volatility. If you would invest 6,660 in Biomarin Pharmaceutical on September 2, 2024 and sell it today you would lose (57.00) from holding Biomarin Pharmaceutical or give up 0.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bausch Health Companies vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Bausch Health Companies |
| Biomarin Pharmaceutical |
Bausch Health and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bausch Health and Biomarin Pharmaceutical
The main advantage of trading using opposite Bausch Health and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Bausch Health vs. Crinetics Pharmaceuticals | Bausch Health vs. Enanta Pharmaceuticals | Bausch Health vs. Amicus Therapeutics | Bausch Health vs. Connect Biopharma Holdings |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |